Combination Therapy Against Multidrug Resistance

ISBN-13: 9780128205761 / Angielski / Miękka / 2020 / 260 str.

Mohmmad Younus Wani; Aijaz Ahmad

Spis treści

1 Combination therapy: Current status and future perspectives Manzoor Ahmad Malik, Mohmmad Younus Wani, and Athar Adil Hashmi

2 Combination therapy against multidrug resistance Musa Marimani

3 Multidrug resistance and the prospects of combination therapy A. Balakrishna, G. Sravya, T.V. Surendra, C. Suresh Reddy, Grigory V. Zyryanov, and N. Bakthavatchala Reddy

4 Combination therapy against human infections caused by Candida species Indresh Kumar Maurya, Ruchi Badoni Semwal, and Deepak Kumar Semwal

5 Metallodrug-driven combination chemotherapy in cancer treatment Afzal Hussain, Mohamed Fahad AlAjmi, Prince F. Iqbal, and Waseem A. Wani

6 Combination antituberculosis therapy: Opportunities and challenges to combat drug-resistant tuberculosis Sudarkodi Sukumar, Md. Zafaryab, Md. Khurshid Alam Khan, Krishnan Hajela, and Mohammad Nasiruddin,

7 Synergistic effect of drugs against multiple drug-resistant swine pathogen Streptococcus suis Shama Khan

8 Combination therapy and multidrug resistance in malaria parasite Abdul Hafiz, Mahmood A. Alam, Othman A. Alghamdi, and Arif Mohammed

9 Combination therapy as an effective tool for treatment of drug-resistant viral infections Musa Marimani, Aijaz Ahmad, and Adriano Duse

10 Combination therapy against human infections caused by viruses Rifat Munir

11 Phenotype screenings of drugs for combination therapy against multidrug resistance Arif Mohammed and Othman A. Alghamdi

12 New approaches for targeting drug resistance through drug combination Shailesh Kumar Singh, Arif Mohammed, Othman A. Alghamdi, and Syed Masood Husain

O autorze

Mohmmad Younus Wani, PhD, Assistant Professor, Department of Chemistry, College of Science, University of Jeddah, Kingdom of Saudi Arabia. Dr. Wani graduated from Jamia Millia Islamia, New Delhi, India in 2013. Received a senior research fellowship from CSIR-India in 2012 and FCT postdoctoral fellowship from Portugal in 2013. Worked as a postdoctoral fellow with Prof. A. Sobral group from 2013-2016 on the development of fungal cell wall targeted antifungal therapies. In fall 2016, Dr. Wani moved to the University of Texas, USA, Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, UTHealth on the development of non-traditional antimicrobial agents and strategies combating multi-drug resistance. He has many international publications, book chapters, and a book, besides many international and national honours and awards to his credit. Dr. Wani is working hard to advance the medicinal chemistry and drug discovery field with new questions and pertinent issues of 21st century. Aijaz Ahmad, PhD, Lecturer, Department of Clinical Microbiology and Infectious Diseases, University of the
Witwatersrand, Johannesburg, South Africa and Medical Scientist, Division of Infection Control, Charlotte Maxeke Johannesburg Academic Hospital, National Health Laboratory Service (NHLS), Johannesburg, South Africa. Dr. Ahmad has specialties in Infectious Diseases, Clinical Microbiology, Biochemistry, Molecular Biology, and Microbial Pathogenesis. He has been awarded South African National Research Foundation Scientist Rating of Y2 (Promising young researchers) and he is a Lifetime fellow member of Scientific Society of Advanced Research and Social Change, a Fellow member of South African Society of Biochemistry and Molecular Biology and a Committee member of National Health Laboratory Services Research and Development Committee.